Only Half Of 2024’s Biggest Launches Belong To Big Pharma

 
• By Andrew McConaghie and Edwin Elmhirst
  
In Vivo Podcast

Candid conversations with C-suite leaders.

Keep up with strategy, innovation and evolving trends across life science industries.

SpotifyApple PodcastsWebsite

More from Market Intelligence

More from In Vivo